JNJ PFE# Stock
T*C
1 楼
Johnson & Johnson (JNJ) down 1.6% and Pfizer (PFE) down 2.1% AH as the
companies put a halt on studies of Alzheimer's drug bapineuzumab, which they
were developing together but which left execs "disappointed.
companies put a halt on studies of Alzheimer's drug bapineuzumab, which they
were developing together but which left execs "disappointed.